Drugs / Lactobacillus delbrueckii bulgaricus
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06241222 | Jan 2018 → Dec 2021 | — | Third Affiliated Hospital, Sun Yat-Sen University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lactobacillus delbrueckii bulgaricus | “After enrollment, pregnant women in the probiotic group received a combination of living Bifidobacterium longum (5 ∗ 106 CFU), Lactobacillus delbrueckii bulgaricus (5 ∗ 105...” NCT06241222 ↗ |
| Route | Oral | “Pregnant individuals in the probiotic group were administered two tablets twice a day (2 g/d) until natural delivery” NCT06241222 ↗ |